Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avadel Pharmaceuticals (DE:AWK)
FRANKFURT:AWK
RESEARCH TOOLSreports
Holding DE:AWK?
Track your performance easily
Avadel Pharmaceuticals (AWK) Ownership Overview
11.23% Insiders
10.92% Mutual Funds
38.65% Other Institutional Investors
8.23% ETFs
30.97% Public Companies and
Individual Investors
The ownership structure of Avadel Pharmaceuticals (DE:AWK) stock is a mix of institutional, retail, and individual investors. Approximately 57.81% of the company’s stock is owned by Institutional Investors, 11.23% is owned by Insiders, and 30.97% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 16, 2024 | xxxxxxxxxxxxx | $24012 | |
| Dec 12, 2024 | xxxxxxxxxxxxx | $52400 | |
| Dec 10, 2024 | Linda Palczuk Director | xxxxxxxxxxxxx | $30540 |
| Dec 10, 2024 | Gregory J Divis Ceo,director | xxxxxxxxxxxxx | $99640 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $18029505 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $22129109 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,685,350 | Insider | 6.33% | 62,152,246 | |
| 4,257,007 | Institution | 4.42% | 46,537,601 | |
| 3,716,242 | Insider | 4.10% | 40,625,958 | |
| 3,680,864 | Institution | 3.82% | 40,239,205 | |
| 3,505,722 | Institution | 3.64% | 38,324,553 | |
| 2,986,085 | Institution | 3.10% | 32,643,881 | |
| 1,687,313 | Institution | 1.75% | 18,445,706 | |
| 1,374,724 | Institution | 1.43% | 15,028,483 | |
| 1,007,046 | Institution | 1.05% | 11,009,027 | |
| 470,341 | Institution | 0.49% | 5,141,768 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,257,007 | Institution | 4.42% | 46,537,601 | |
| 2,986,085 | Institution | 3.10% | 32,643,881 | |
| 1,007,046 | Institution | 1.05% | 11,009,027 | |
| 468,323 | Institution | 0.49% | 5,119,707 | |
| 425,000 | Institution | 0.44% | 4,646,100 | |
| 280,544 | Institution | 0.29% | 3,066,907 | |
| 222,798 | Institution | 0.23% | 2,435,628 | |
| 199,683 | Institution | 0.21% | 2,182,935 | |
| 100,497 | Institution | 0.10% | 1,098,633 | |
| 77,165 | Institution | 0.08% | 843,568 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Avadel Pharmaceuticals (DE:AWK)?
According to the latest TipRanks data, approximately 38.65% of the company's stock is held by institutional investors, 11.23% is held by insiders, and 30.97% is held by retail investors.
What percentage of Avadel Pharmaceuticals (DE:AWK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.65% of Avadel Pharmaceuticals (DE:AWK) stock is held by institutional investors.
What percentage of Avadel Pharmaceuticals (DE:AWK) stock is held by retail investors?
According to the latest TipRanks data, approximately 30.97% of Avadel Pharmaceuticals (DE:AWK) stock is held by retail investors.
Who owns the most shares of Avadel Pharmaceuticals (DE:AWK)?
Jeffrey L. Gendell owns the most shares of Avadel Pharmaceuticals (DE:AWK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.